Medulloblastoma and Cowden syndrome: Further evidence of an association.

Cowden syndrome Medulloblastoma PTEN

Journal

Free neuropathology
ISSN: 2699-4445
Titre abrégé: Free Neuropathol
Pays: Germany
ID NLM: 101768755

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 02 12 2021
accepted: 02 01 2022
medline: 11 1 2022
pubmed: 11 1 2022
entrez: 7 6 2023
Statut: epublish

Résumé

Cowden syndrome (CS) is an autosomal dominant hamartoma and tumor predisposition syndrome caused by heterozygous pathogenic germline variants in

Identifiants

pubmed: 37284158
doi: 10.17879/freeneuropathology-2022-3684
pmc: PMC10209873
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Eur J Paediatr Neurol. 2015 Mar;19(2):188-92
pubmed: 25549896
Nature. 2020 Apr;580(7803):396-401
pubmed: 32296180
J Stroke Cerebrovasc Dis. 2016 Jun;25(6):e93-4
pubmed: 27105569
J Oral Maxillofac Surg. 1989 Mar;47(3):291-4
pubmed: 2921660
Mol Genet Genomic Med. 2020 Sep;8(9):e1302
pubmed: 32419380
Nat Genet. 2001 Dec;29(4):396-403
pubmed: 11726926
AJNR Am J Neuroradiol. 2012 Jun;33(6):1007-13
pubmed: 22241393
Nature. 2018 Mar 15;555(7696):321-327
pubmed: 29489754
Lancet Oncol. 2018 Jun;19(6):785-798
pubmed: 29753700
Nat Commun. 2021 Mar 19;12(1):1749
pubmed: 33741928
Hered Cancer Clin Pract. 2010 Jun 17;8(1):6
pubmed: 20565722
Nature. 2012 Aug 2;488(7409):49-56
pubmed: 22832581
Cancer Cell. 2017 Jun 12;31(6):737-754.e6
pubmed: 28609654
BMJ Case Rep. 2017 Aug 28;2017:
pubmed: 28847996
J Med Genet. 2000 Nov;37(11):828-30
pubmed: 11073535
Cancer Res. 2013 Dec 1;73(23):7034-42
pubmed: 24154871
Pediatr Neurol. 2015 Jul;53(1):31-46
pubmed: 26092413
Clin Cancer Res. 2012 Jan 15;18(2):400-7
pubmed: 22252256
PLoS One. 2010 May 26;5(5):e10849
pubmed: 20520772
Clin Cancer Res. 2009 Apr 1;15(7):2463-71
pubmed: 19276247
Nat Genet. 2001 Dec;29(4):404-11
pubmed: 11726927
J Neuropathol Exp Neurol. 2021 Apr 16;80(5):419-430
pubmed: 33870422
F1000Res. 2019 Oct 29;8:
pubmed: 31700613

Auteurs

Steffen Albrecht (S)

Department of Pathology, McGill University, Montreal, QC Canada.

Barbara Miedzybrodzki (B)

Division of Dermatology, Department of Pediatrics, McGill University Health Centre, Montreal Children's Hospital, Montreal, QC Canada.

Laura Palma (L)

Department of Human Genetics, McGill University, Montreal, QC Canada.
Division of Medical Genetics, Department of Specialized Medicine, McGill University Health Centre, Montreal, QC Canada.

Van Hung Nguyen (VH)

Department of Pathology, McGill University, Montreal, QC Canada.

Roy W R Dudley (RWR)

Division of Neurosurgery, Department of Pediatric Surgery, Montreal Children's Hospital, McGill University Health Centre, Montreal, QC Canada.

Torsten Pietsch (T)

Department of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn Medical Center, Bonn Germany.

Tobias Goschzik (T)

Department of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn Medical Center, Bonn Germany.

Nada Jabado (N)

Department of Human Genetics, McGill University, Montreal, QC Canada.
Department of Pediatrics, McGill University, Montreal, QC Canada.
The Research Institute of the McGill University Health Centre, Child Health and Human Development Program, Montreal, QC Canada.

Catherine Goudie (C)

The Research Institute of the McGill University Health Centre, Child Health and Human Development Program, Montreal, QC Canada.
Division of Hematology-Oncology, Montreal Children's Hospital, Department of Pediatrics, McGill University, Montreal, QC Canada.

William D Foulkes (WD)

Department of Human Genetics, McGill University, Montreal, QC Canada.
Cancer Axis, Lady Davis Institute, The Jewish General Hospital, Montreal, QC Canada.
Cancer Research Program, The Research Institute of the McGill University Health Centre, Montreal, QC Canada.
Gerald Bronfman Department of Oncology, McGill University, Montreal, QC Canada.

Classifications MeSH